DG Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-84,213
| Closed | -$513K | – | 16 |
|
|
2025
Q1 | $513K | Sell |
84,213
-1,030,479
| -92% | -$6.28M | 0.18% | 13 |
|
|
2024
Q4 | $7.04M | Sell |
1,114,692
-407,512
| -27% | -$2.58M | 2.37% | 8 |
|
|
2024
Q3 | $7.61M | Sell |
1,522,204
-112,607
| -7% | -$563K | 3.45% | 8 |
|
|
2024
Q2 | $9.99M | Buy |
1,634,811
+123,148
| +8% | +$752K | 3.85% | 6 |
|
|
2024
Q1 | $16.8M | Buy |
1,511,663
+436,029
| +41% | +$4.85M | 10.3% | 3 |
|
|
2023
Q4 | $12.1M | Sell |
1,075,634
-67,465
| -6% | -$757K | 7.46% | 8 |
|
|
2023
Q3 | $8.58M | Buy |
1,143,099
+68,445
| +6% | +$514K | 4.7% | 10 |
|
|
2023
Q2 | $9.49M | Sell |
1,074,654
-175,442
| -14% | -$1.55M | 4.23% | 9 |
|
|
2023
Q1 | $10.4M | Buy |
1,250,096
+228,144
| +22% | +$1.9M | 5.85% | 7 |
|
|
2022
Q4 | $9.81M | Buy |
1,021,952
+16,851
| +2% | +$162K | 5.66% | 8 |
|
|
2022
Q3 | $8.14M | Sell |
1,005,101
-205,537
| -17% | -$1.66M | 3.58% | 13 |
|
|
2022
Q2 | $6.84M | Hold |
1,210,638
| – | – | 2.46% | 16 |
|
|
2022
Q1 | $6.78M | Buy |
1,210,638
+51,249
| +4% | +$287K | 1.36% | 20 |
|
|
2021
Q4 | $5.1M | Buy |
1,159,389
+540,938
| +87% | +$2.38M | 0.84% | 20 |
|
|
2021
Q3 | $5.83M | Buy |
618,451
+29,678
| +5% | +$280K | 1.18% | 21 |
|
|
2021
Q2 | $4.29M | Buy |
+588,773
| New | +$4.29M | 0.93% | 25 |
|